REQUEST A DEMO
Total
USD $0.00
Search more companies

Nam Sap Laboratories (Thailand) Co Ltd (Thailand)

Main Activities: Surgical and Medical Instrument Manufacturing
Full name: Nam Sap Laboratories (Thailand) Co Ltd Profile Updated: January 27, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Nam Sap Laboratories (Thailand) Co Ltd is a company engaged in the manufacture of medical instruments and equipment. The company specializes in the production of medical devices and related equipment, excluding dental instruments and supplies. Its operations support healthcare and medical service providers through the development and manufacturing of medical products. The company was incorporated in 2019 and is based in Bangkok, Thailand.

Headquarters
1/11-12 Soi Lat Pla Khao 50 Lat Phrao
Bangkok , Special Governed District of; Central Thailand; Postal Code: 10230

Contact Details: Purchase the Nam Sap Laboratories (Thailand) Co Ltd report to view the information.

Website: https://namsaplaboratory.co.th/

Basic Information
Registered Capital:
Purchase the Nam Sap Laboratories (Thailand) Co Ltd report to view the information.
Financial Auditors:
Purchase the Nam Sap Laboratories (Thailand) Co Ltd report to view the information.
Incorporation Date:
February 24, 2026
Key Executives
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Nam Sap Laboratories (Thailand) Co Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Net sales revenue
-4.38%
Total operating revenue
-4.35%
Operating Profit/Loss (EBIT)
12.95%
EBITDA
12.95%
Net Profit/Loss for the Period
21.62%
Total Assets
61.69%
Total Equity
26.17%
Operating Profit Margin (ROS)
2.08%
Net Profit Margin
1.71%
Return on Equity (ROE)
-0.81%
Debt/Equity
5.9%
Quick Ratio
1.08%
Cash Ratio
-0.22%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?